Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
RESEARCH TOOLSreports
Holding GZPHF?
Track your performance easily
GZPHF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.72 - $3.23
Previous Close$2.42
Volume2.00K
Average Volume (3M)N/A
Market Cap
$6.30B
Enterprise Value$4.97B
Total Cash (Recent Filing)¥22.56B
Total Debt (Recent Filing)¥11.43B
Price to Earnings (P/E)8.3
Beta0.33
Next Earnings
Mar 17, 2025EPS Estimate
$0.04Last Dividend Ex-Date
Oct 15, 2024Dividend Yield6.74%
Share Statistics
EPS (TTM)0.29
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.14
R-Squared0.01
Alpha-0.00023
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.45
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.79Price Target Upside-3.12% Downside
Rating ConsensusHold
Number of Analyst Covering1
Guangzhou Baiyunshan Pharmaceutical Holdings Company News
PremiumCompany Announcements
Guangzhou Baiyunshan Reports Mixed Financial Results
PremiumCompany Announcements
Guangzhou Baiyunshan’s Strategic Asset Disposal UnveiledPremiumCompany Announcements
Guangzhou Baiyunshan Schedules Financial Review Meeting
PremiumCompany Announcements
Guangzhou Baiyunshan’s Generic Drug Wins Approval
PremiumCompany Announcements
Guangzhou Baiyunshan’s EGM Approves All Resolutions
PremiumCompany Announcements
Guangzhou Baiyunshan Declares Mid-Year Dividend
PremiumCompany Announcements
Baiyunshan Pharma Announces Shareholder Meeting
PremiumCompany Announcements
Baiyunshan’s Generic Drug Passes Key EvaluationOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.10% Mutual Funds
― Other Institutional Investors
93.12% Public Companies and
Individual Investors
GZPHF FAQ
What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price range in the past 12 months?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H lowest stock price was $1.72 and its highest was $3.23 in the past 12 months.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap?
Currently, no data Available
When is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date is Mar 17, 2025 which is in 123 days.
How were Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s earnings last quarter?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H released its earnings results on Oct 25, 2024. The company reported $0.062 earnings per share for the quarter, the consensus estimate of $0.062 by $0.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H overvalued?
According to Wall Street analysts Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price is currently Overvalued.
Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pay dividends?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pays a Annually dividend of $0.06 which represents an annual dividend yield of 6.74%. See more information on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H dividends here
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate is $0.04.
How many shares outstanding does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H have?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H has 219,900,000 shares outstanding.
What happened to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price movement after its last earnings report?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H reported an EPS of $0.062 in its last earnings report, expectations of $0.062. Following the earnings report the stock price went up 0.408%.
Which hedge fund is a major shareholder of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?
Currently, no hedge funds are holding shares in GZPHF
---
Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.27%
12-Months-Change
Fundamentals
Return on Equity
9.60%
Trailing 12-Months
Asset Growth
10.97%
Trailing 12-Months
Company Description
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its operations are divided into three main segments: pharmaceutical manufacturing, pharmaceutical distribution & retail, and health products. The greater portion of its revenue comes from its pharmaceutical activities in patent medicine, raw materials, distribution, and retail. The rest of its revenues come from its beverage, food, cosmetics, and health products. The company's primary market is China.
---
GZPHF Stock 12 Month Forecast
Average Price Target
$2.79
▼(-3.12% Downside)
Technical Analysis
---